Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Cell Cycle. 2010 Feb 1;9(3):487-97. doi: 10.4161/cc.9.3.10508.
Akt (also known as PKB) signaling orchestrates many aspects of biological functions and, importantly, its deregulation is linked to cancer development. Akt activity is well-known regulated through its phosphorylation at T308 and S473 by PDK1 and mTOrC2, respectively. Although in the last decade the research has been primarily focused on Akt phosphorylation and its role in Akt activation and functions, other posttranslational modifications on Akt have never been reported. Until very recently, a novel posttranslational modification on Akt termed ubiquitination was identified and shown to play an important role in Akt activation. The cancer-associated Akt mutant recently identified in a subset of human cancers displays enhanced Akt ubiquitination, in turn contributing to Akt hyperactivation, suggesting a potential role of Akt ubiquitination in cancers. Thus, this novel posttranslational modification on Akt reveals an exciting avenue that has advanced our current understandings of how Akt signaling activation is regulated.
Akt(也称为 PKB)信号转导协调了许多生物学功能的方面,重要的是,其失调与癌症的发展有关。Akt 的活性通过 PDK1 和 mTORC2 分别在 T308 和 S473 处的磷酸化来很好地调节。尽管在过去的十年中,研究主要集中在 Akt 的磷酸化及其在 Akt 激活和功能中的作用,但从未报道过 Akt 上的其他翻译后修饰。直到最近,才发现 Akt 上的一种新的翻译后修饰,即泛素化,并表明其在 Akt 激活中发挥重要作用。最近在人类癌症的一部分中发现的与癌症相关的 Akt 突变体显示出增强的 Akt 泛素化,从而导致 Akt 的过度激活,提示 Akt 泛素化在癌症中可能具有作用。因此,Akt 上的这种新的翻译后修饰揭示了一个令人兴奋的途径,这进一步提高了我们对 Akt 信号转导激活是如何受到调节的理解。